君合盟公布B+轮融资，融资额近2.5亿东说念主民币，投资方为国投创合、弘盛成本等

证券之星音讯，字据天眼查APP于9月9日公布的信息整理，君合盟生物制药（杭州）有限公司公布B+轮融资，融资额近2.5亿东说念主民币，参与投资的机构包括国投创合，弘盛成本，元禾控股，新氧科技。

君合盟生物制药（杭州）有限公司的历史融资如下：

君合盟是一家专注于雄壮市集前沿卵白药物的国外化鼎新企业。依托中枢团队20余年的卵白药物研发与产业化教训，君合盟搭建了兼具成药性和鼎新性的重组卵白药物修复平台，隐敝了重组卵白的高效抒发系统、特有的微变性折柳纯化技艺、卵白体外折叠与自拼装体系、以及长效缓释等高壁垒、已结束产业化的技艺储备。此外，公司扩充团队也曾合作职责10余年，从产物立项、研发、坐褥、临床到上市，团队也曾共同修复多款卵白药物，团队的高相识性、高合作力、强凝华力为公司永久发展添砖加瓦。君合盟的研发管线布局围绕代谢、医好意思等雄壮市集前沿卵白药物限制，其中先导产物聚焦在重组A型肉毒素、孕育激素等具有销耗属性的重组卵白药物。

数据开端：天眼查APP

以上实质为证券之星据公开信息整理，由智能算法生成，不组成投资提出。

","del":0,"gnid":"9251bc7d2cf88cf35","img_data":[{"flag":"2","img":[{"desc":"","height":"445","title":"","url":"http://p9.img.360kuai.com/t11508c75c82508685986f8dbcb.jpg","width":"540"}]}],"original":0,"pat":"art_src_1,fts0,sts0","powerby":"cache","pub_time":1726054236000,"pure":"","rawurl":"http://zm.news.so.com/fda85910eef9140e2cf107c83cfb98a7","redirect":0,"rptid":"39e434f7b9c5b25a","rss_ext":[],"s":"t","src":"证券之星","tag":[{"clk":"keconomy_1:天眼查","k":"天眼查","u":""},{"clk":"keconomy_1:融资","k":"融资","u":""}],"title":"君合盟公布B+轮融资，融资额近2.5亿东说念主民币，投资方为国投创合、弘盛成本等","type":"zmt","wapurl":"http://zm.news.so.com/fda85910eef9140e2cf107c83cfb98a7","ytag":"财经:金融证券:基金","zmt":{"brand":{},"cert":"证券之星官方账号","desc":"证券之星是专为华东说念主交游者提供工作的财经学派网站。","fans_num":27771,"id":"1300744758","is_brand":"0","name":"证券之星","new_verify":"5","pic":"https://p0.img.360kuai.com/t01e98b243aa76b141c.png","real":1,"textimg":"https://p9.img.360kuai.com/bl/0_3/t017c4d51e87f46986f.png","verify":"0"},"zmt_status":0}","errmsg":"","errno":0}